BR9813164A - Método de uso de inibidores da ciclooxigenase-2 na manutenção do ducto arterial fetal durante o tratamento e prevenção de dores prematuras de parto - Google Patents

Método de uso de inibidores da ciclooxigenase-2 na manutenção do ducto arterial fetal durante o tratamento e prevenção de dores prematuras de parto

Info

Publication number
BR9813164A
BR9813164A BR9813164-8A BR9813164A BR9813164A BR 9813164 A BR9813164 A BR 9813164A BR 9813164 A BR9813164 A BR 9813164A BR 9813164 A BR9813164 A BR 9813164A
Authority
BR
Brazil
Prior art keywords
inhibitors
cyclooxygenase
premature labor
maintain
labor pains
Prior art date
Application number
BR9813164-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Philip Needleman
Jaime Masferrer
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of BR9813164A publication Critical patent/BR9813164A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR9813164-8A 1997-10-31 1998-10-27 Método de uso de inibidores da ciclooxigenase-2 na manutenção do ducto arterial fetal durante o tratamento e prevenção de dores prematuras de parto BR9813164A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6388997P 1997-10-31 1997-10-31
PCT/US1998/022246 WO1999022720A2 (en) 1997-10-31 1998-10-27 Selective cyclooxygenase-2 inhibitors against premature labor

Publications (1)

Publication Number Publication Date
BR9813164A true BR9813164A (pt) 2000-08-22

Family

ID=22052179

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9813164-8A BR9813164A (pt) 1997-10-31 1998-10-27 Método de uso de inibidores da ciclooxigenase-2 na manutenção do ducto arterial fetal durante o tratamento e prevenção de dores prematuras de parto

Country Status (9)

Country Link
EP (1) EP1027048A2 (https=)
JP (1) JP2001521889A (https=)
AR (1) AR014000A1 (https=)
AU (1) AU758566B2 (https=)
BR (1) BR9813164A (https=)
CA (1) CA2308639A1 (https=)
TW (2) TW200404535A (https=)
WO (1) WO1999022720A2 (https=)
ZA (1) ZA989876B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001274858A1 (en) * 2000-06-08 2001-12-17 Board Of Regents, The University Of Texas System Heterocycle derivatives and methods of use for treating anthrax infection
EP1745791B1 (en) 2003-05-07 2013-06-26 Osteologix A/S Treating cartilage/bone conditions with water-soluble strontium salts

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6718494A (en) * 1993-05-13 1994-12-12 Merck Frosst Canada Inc. 2-substituted-3,4-diarylthiophene derivatives as inhibitors of cyclooxygenase
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
WO1997031631A1 (en) * 1996-02-27 1997-09-04 Rpms Technology Limited Cox-2 selective inhibitors for managing labour and uterine contractions
US5677318A (en) * 1996-07-11 1997-10-14 Merck Frosst Canada, Inc. Diphenyl-1,2-3-thiadiazoles as anti-inflammatory agents

Also Published As

Publication number Publication date
EP1027048A2 (en) 2000-08-16
WO1999022720A3 (en) 1999-08-26
ZA989876B (en) 1999-10-29
JP2001521889A (ja) 2001-11-13
AU1192699A (en) 1999-05-24
TW577739B (en) 2004-03-01
AR014000A1 (es) 2001-01-31
TW200404535A (en) 2004-04-01
WO1999022720A2 (en) 1999-05-14
AU758566B2 (en) 2003-03-27
CA2308639A1 (en) 1999-05-14

Similar Documents

Publication Publication Date Title
BR9812484A (pt) Terapia combinada para erradicação de hcv-rna detectável em pacientes com infecção crÈnica por hepatite c
ES2160707T3 (es) Composiciones que comprenden agentes deteriorantes del adn y p53.
DE69329856D1 (de) Ester derivate von 4-aza-steroiden
WO1995033464A3 (en) Retroviral protease inhibitor combinations
BR9712314A (pt) Método de uso de inibidores de ciclooxigenase-2 no tratamento e prevenção de neoplasia
ATE255589T1 (de) Kristallin form i von clarithromycin
BR0014384A (pt) Compostos para o tratamento da isquémia
BRPI9710372B8 (pt) composto, e, composição farmacêutica.
ATE249421T1 (de) Inhibitoren der alpha4-beta1 vermittelten zelladhäsion
TR200200986T2 (tr) C-aril glukozid SGLT2 önleyicileri.
BR0001468A (pt) ácidos dioxiciclopentil hidroxânicos
PT705100E (pt) Guanidinas substituidas terapeuticas
BR9812381A (pt) Peptopiranosilnucleosìdeo, seu preparo e uso
ATE316962T1 (de) Pyrimidin-derivate als selective inhibitoren von cox-2
PT1144365E (pt) Inibidores da adesao de celulas mediada por alfa4beta1
BR9813319A (pt) Composto, composição farmacêutica para tratamento de infecções bacterianas, e, processos para tratar infecções bacterianas e para preparar um composto
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
IL143594A0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
DK1291018T3 (da) Phosphonatananaloger til mannose-6phosphat og deres anvendelse i behandlingen af sår og fibrotiske lidelser
BR0006301A (pt) Macrólidos antibacterianos e pró-cinéticos
EP1085859A4 (en) WIND TREATMENT TO INHIBIT ADENOSINETRIPHOSPHOTERIBOSYL TRANSFERASE
BR9611472A (pt) Compostos de di-terc-butilfenol contendo enxofre úteis como agentes antiinflamatórios
BR9813164A (pt) Método de uso de inibidores da ciclooxigenase-2 na manutenção do ducto arterial fetal durante o tratamento e prevenção de dores prematuras de parto

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI.